Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
TARO-RAMIPRIL SUN PHARMA CANADA INC Actual shortage 10MG Updated Report 2025-07-19 263203
TARO-PHENYTOIN TARO PHARMACEUTICALS INC Actual shortage 125MG Updated Report 2025-07-19 262087
RAPAMUNE PFIZER CANADA ULC Resolved 1MG Updated Report 2025-07-19 262711
TARO-EZETIMIBE SUN PHARMA CANADA INC Actual shortage 10MG Updated Report 2025-07-19 263188
TARO-RAMIPRIL SUN PHARMA CANADA INC Actual shortage 5MG Updated Report 2025-07-19 263200
EFUDEX BAUSCH HEALTH, CANADA INC. Resolved 5% Updated Report 2025-07-19 262320
MYLAN-NAPROXEN/ESOMEPRAZOLE MR MYLAN PHARMACEUTICALS ULC Actual shortage 20MG 500MG Updated Report 2025-07-19 262910
ALYSENA 21 APOTEX INC Actual shortage 100MCG 20MCG Updated Report 2025-07-18 261623
APO-RISPERIDONE APOTEX INC Resolved 0.50MG Updated Report 2025-07-18 258827
APO-LEVOTHYROXINE APOTEX INC Resolved 200MCG Updated Report 2025-07-18 257525

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
ACULAR LS ABBVIE CORPORATION Discontinued 0.4% Updated Report 2025-07-19 248365
SELECT 1/35 (28-DAY) PFIZER CANADA ULC Discontinued 0.035MG 1.0MG Updated Report 2025-07-11 259551
CODEINE 30 LABORATOIRE RIVA INC. To be discontinued 30MG New Report 2025-07-10 262503
ZENHALE ORGANON CANADA INC. To be discontinued 200MCG 5MCG New Report 2025-07-07 262162
ZENHALE ORGANON CANADA INC. To be discontinued 5MCG 100MCG New Report 2025-07-07 262159